The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis
Clinical trial NCT05234554 · COMPLETED
Trial details
- NCT number
- NCT05234554
- Sponsor
- Aldeyra Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-21
- Primary completion
- 2023-04-22
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.